Medical Supply Acquisition in Italy and the United States in the Era of COVID-19: The Case for Strategic Procurement and Public–Private Partnerships

DOI10.1177/0275074020942061
AuthorEric J. Boyer,Niccolò Cusumano,Veronica Vecchi
Published date01 August 2020
Date01 August 2020
Subject MatterThe Case For & Against BureaucracyChallenges Acquiring Personal Protective Equipment & the Impact on Supply Chains
https://doi.org/10.1177/0275074020942061
American Review of Public Administration
2020, Vol. 50(6-7) 642 –649
© The Author(s) 2020
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/0275074020942061
journals.sagepub.com/home/arp
Challenges Acquiring Personal Protective Equipment & the Impact on Supply Chains
Introduction
The crisis surrounding the 2019 novel coronavirus
(COVID-19) highlights the case for strategic procurement of
medical supplies, such as ventilators and personal protective
equipment (PPE), whose global supply chains were initially
disrupted by the lockdown in China and, subsequently, by a
surge in global demand. Responding to a global emergency
such as COVID-19 requires the development of systems that
can improve disaster resilience (Holling, 1973; Manyena,
2006), and efforts to expand and sustain the procurement of
medical supplies. The challenge is that public procurement
transfers higher levels of contract risk onto public agencies
in times of disaster (Buor, 2019; Gabler et al., 2017;
McKnight & Linnenluecke, 2016; Walker et al., 2013).
Procuring authorities require goods and services at the same
time, setting off bidding wars that escalate the costs of sup-
plies. Because of the lack of suppliers, procurement officials
often rely on vendors from gray markets (Antia et al., 2006;
Huang et al., 2004), including those who may have little or
no experience working for the government or even in supply-
ing the products they have been contracted to provide.
Procurement officials also rely on thin markets (Beck &
Maher, 1986; Theobald & Price, 1984), whereby the number
of available vendors is limited and the urgent need for medi-
cal supplies requires sole-sourced, no-bid contracts.
This article sheds light on the main challenges faced by
two of the countries most affected by COVID-19, Italy and
the United States, which are characterized by opposite
health care systems. Private providers and private insur-
ance companies characterize the U.S. system; in Italy,
there is a national health care service with universal cover-
age, financed by general taxation. In both countries, there
are procuring agencies that serve a network of hospitals.
The procurement of medical supplies in Italy and the
United States have traditionally prioritized contractor
competition, to avoid service cuts in the former and to
increase profitability in the latter (Meehan et al., 2016).
For example, U.S. hospitals and their purchasing agents
have come to rely less on their own stockpiles of supplies
of PPEs (Volland et al., 2017) and have, instead, turned to
just-in-time inventories to bring down costs (Swanson,
2020). In both the United States and Italy, hospital pur-
chasing depends on foreign manufacturing and interna-
tional supply chains that provide critical input products for
942061ARPXXX10.1177/0275074020942061The American Review of Public AdministrationVecchi et al.
research-article2020
1Bocconi University, Milano, Italy
2The University of Texas at El Paso, USA
Corresponding Author:
Veronica Vecchi, SDA Bocconi School of Management & Cergas, Bocconi
University, Via Roberto Sarfatti, 25, 20100 Milano, Italy.
Email: veronica.vecchi@unibocconi.it
Medical Supply Acquisition in Italy and
the United States in the Era of COVID-19:
The Case for Strategic Procurement and
Public–Private Partnerships
Veronica Vecchi1, Niccolò Cusumano1, and Eric J. Boyer2
Abstract
The article analyzes contracting challenges faced by Italian health care authorities and U.S. procurement officials in the
immediate aftermath of the COVID-19 crisis, and it provides practitioner-derived lessons for improving procurement in
times of disaster. The lessons we have learned so far emphasize (a) the need to recognize the strategic role of procurement,
(b) empowering procurement officials, (c) formalized coordinative mechanisms cannot ensure effectiveness without trust
among different governance levels, (d) the ability to identify reliable and proactive suppliers of personal protective equipment,
(e) the importance of stimulating the economic market to diversify the production of needed materials and to ensure a more
risk-resilient supply chain, and (f) the critical role of public–private collaborations to ensure responsiveness and resilience of
health care systems.
Keywords
COVID-19, public procurement, public-private partnership, strategic procurement, disaster resilience

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT